New 52 Week Low Today

AnGes Inc 4563.T-JP:Tokyo Stock Exchange

*Data is delayed | Exchange | JPY
Last | 3:00 PM JST
50.00quote price arrow down-1.00 (-1.96%)
Volume
2,230,900
52 week range
50.00 - 143.00
Loading...
  • Open51.00
  • Day High52.00
  • Day Low50.00
  • Prev Close51.00
  • 52 Week High143.00
  • 52 Week High Date05/25/23
  • 52 Week Low50.00
  • 52 Week Low Date04/19/24

Key Stats

  • Market Cap72.8M
  • Shares Out198.47M
  • 10 Day Average Volume2.17M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-30.56

KEY STATS

  • Open51.00
  • Day High52.00
  • Day Low50.00
  • Prev Close51.00
  • 52 Week High143.00
  • 52 Week High Date05/25/23
  • 52 Week Low50.00
  • 52 Week Low Date04/19/24
  • Market Cap72.8M
  • Shares Out198.47M
  • 10 Day Average Volume2.17M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-30.56

RATIOS/PROFITABILITY

  • EPS (TTM)-39.80
  • P/E (TTM)-1.26
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On AnGes Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
AnGes, Inc., formerly AnGes MG, Inc., is a Japan-based company mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidated subsidiaries. On January 31, 2013, the Company sold a 95.3% stake of a Osaka-based subsidiary to...
Ei Yamada
President, Executive President, Chief Executive Officer, President of Subsidiary, Representative Director
Address
Saito Bio-Incubator, 7-7-15, Saito-Asagi
Ibaraki-shi, OSK
567-0085
Japan